Project Details
Description
PROJECT SUMMARY
Protein post-translational modifications are ubiquitous events that regulate the core functions of the cell. This
project focuses on lysine acetylation, which was first characterized in the context of chromatin structure and
transcription. Recent proteomic data demonstrate that lysine acetylation is ubiquitous among both nuclear and
cytosolic proteins. However, the mechanisms whereby lysine acetylation regulates function are still poorly
understood. To overcome this knowledge gap, the PI’s laboratory has recently established protocols for transfer
of 13C-acetyl groups to recombinant proteins and developed nuclear magnetic resonance (NMR) experiments
that provide one resonance per acetyllysine sidechain without introducing sterically bulky chemical modifications
that would impair investigation of downstream interactions. The current proposal seeks to generalize this 13C-
enhanced NMR strategy to broaden the enzyme/substrate scope, enable structure determination for
complexes, and demonstrate the utility of the method for non-histone proteins. This plan aligns with the
PI’s track record of technology development in 13C direct-detect biomolecular NMR, which is used to probe the
biophysics of disordered proteins and the complexes they form. In this context, the current project’s first specific
aim is to develop a broad platform for production and chemical shift characterization of acetyllysine. To
demonstrate breadth while using well-described systems for proof-of-concept, the approach will target
Ada2/Gcn5, p300, and MOF to represent the three well annotated families of nuclear lysine acetyltransferases,
using histone H3 and H4 as substrates. To enable chemical shift assignment, NMR pulse sequences will be
developed that correlate acetyllysine resonances with backbone chemical shifts that define position in the
primary structure of proteins. The second specific aim is to design NMR experiments that will enable structure
determination of complexes with bound acetyllysine. The approach will be to develop a set of 3D 1H- and 13C-
detect nuclear Overhauser and exchange (NOESY) spectroscopy techniques based on established isotope
filtering platforms. Utility will be demonstrated by solving structures of histone tails in complex with Gcn5 and
Brd4 bromodomains, for which high resolution crystal structures are available as gold-standards for assessment.
The third specific aim is to demonstrate the applicability of the new technology beyond histone peptides using
reconstituted nucleosomes and the transactivation domain of FoxO1 as biomedical examples. FoxO1
acetylation, which is catalyzed by p300, read by Brd4, and reversed by Sirt6 serves as the capstone. The new
technology proposed here will enable applications including authentication of in vitro derived acetylation patterns
against those known from proteomics, investigation of novel binding modes as new reader proteins are
discovered, and determination of solution NMR structures based on isotope filtered NOE measurement. The
generality of the developed technology will provide sustained benefits for the transcription and signaling
communities, potentially driving translation of biological toward the clinic.
| Status | Active |
|---|---|
| Effective start/end date | 7/1/25 → 3/31/26 |
Funding
- National Institute of General Medical Sciences: $349,074.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.